CMMI Demos’ Future Unclear After Trump Revokes Biden’s Drug Pricing EO

By Gabrielle Wanneh, Maaisha Osman / January 22, 2025 at 8:10 PM

Stakeholders are watching to see what President Donald Trump’s revocation of a Biden-era executive order on drug pricing will mean for three CMS innovation Center demonstrations spurred by the EO, but which for now appear to be continuing.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

CMMI Demos’ Future Unclear After Trump Revokes Biden’s Drug Pricing EO

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.